PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ELAN vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ELAN and SPY is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

ELAN vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elanco Animal Health Incorporated (ELAN) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%NovemberDecember2025FebruaryMarchApril
-76.56%
99.71%
ELAN
SPY

Key characteristics

Sharpe Ratio

ELAN:

-0.73

SPY:

0.30

Sortino Ratio

ELAN:

-0.95

SPY:

0.56

Omega Ratio

ELAN:

0.87

SPY:

1.08

Calmar Ratio

ELAN:

-0.49

SPY:

0.31

Martin Ratio

ELAN:

-1.29

SPY:

1.40

Ulcer Index

ELAN:

29.63%

SPY:

4.18%

Daily Std Dev

ELAN:

52.32%

SPY:

19.64%

Max Drawdown

ELAN:

-78.00%

SPY:

-55.19%

Current Drawdown

ELAN:

-77.02%

SPY:

-13.86%

Returns By Period

In the year-to-date period, ELAN achieves a -30.31% return, which is significantly lower than SPY's -9.91% return.


ELAN

YTD

-30.31%

1M

-21.92%

6M

-34.22%

1Y

-37.06%

5Y*

-19.10%

10Y*

N/A

SPY

YTD

-9.91%

1M

-5.89%

6M

-9.03%

1Y

6.50%

5Y*

14.62%

10Y*

11.57%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ELAN vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELAN
The Risk-Adjusted Performance Rank of ELAN is 1818
Overall Rank
The Sharpe Ratio Rank of ELAN is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of ELAN is 1616
Sortino Ratio Rank
The Omega Ratio Rank of ELAN is 1515
Omega Ratio Rank
The Calmar Ratio Rank of ELAN is 2323
Calmar Ratio Rank
The Martin Ratio Rank of ELAN is 2020
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 5757
Overall Rank
The Sharpe Ratio Rank of SPY is 5454
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 5656
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 5858
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 5959
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 5858
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ELAN vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ELAN, currently valued at -0.73, compared to the broader market-2.00-1.000.001.002.003.00
ELAN: -0.73
SPY: 0.30
The chart of Sortino ratio for ELAN, currently valued at -0.95, compared to the broader market-6.00-4.00-2.000.002.004.00
ELAN: -0.95
SPY: 0.56
The chart of Omega ratio for ELAN, currently valued at 0.87, compared to the broader market0.501.001.502.00
ELAN: 0.87
SPY: 1.08
The chart of Calmar ratio for ELAN, currently valued at -0.49, compared to the broader market0.001.002.003.004.00
ELAN: -0.49
SPY: 0.31
The chart of Martin ratio for ELAN, currently valued at -1.29, compared to the broader market-5.000.005.0010.0015.0020.00
ELAN: -1.29
SPY: 1.40

The current ELAN Sharpe Ratio is -0.73, which is lower than the SPY Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of ELAN and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
-0.73
0.30
ELAN
SPY

Dividends

ELAN vs. SPY - Dividend Comparison

ELAN has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.36%.


TTM20242023202220212020201920182017201620152014
ELAN
Elanco Animal Health Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.36%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

ELAN vs. SPY - Drawdown Comparison

The maximum ELAN drawdown since its inception was -78.00%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for ELAN and SPY. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-77.02%
-13.86%
ELAN
SPY

Volatility

ELAN vs. SPY - Volatility Comparison

Elanco Animal Health Incorporated (ELAN) has a higher volatility of 22.01% compared to SPDR S&P 500 ETF (SPY) at 14.52%. This indicates that ELAN's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
22.01%
14.52%
ELAN
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab